Abiopharma

Net Asset Value(s)

Axsome Therapeutics Hosts AUVELITY® FDA Approval Investor Event Featuring Expert Thought Leader

Owens Corning Completes Sale of Glass Reinforcements Business to Praana Group

Ionis to present at upcoming investor conferences

San Francisco’s Luxury Home Sales Jump 22% As Median Price Nears $7M

Placements: Receipt of Listing and Quotation Notice

Molecular Partners publishes Phase 1 MP0317 data in Nature Cancer demonstrating tumor-localized CD40 activation and tumor microenvironment remodeling

Ispire Technology Inc. Schedules Fiscal Third Quarter 2026 Earnings Conference Call USA - English APAC - English

MapLight Therapeutics Announces Completion of Enrollment in ZEPHYR Phase 2 Trial and Updates Expected Timing of Topline Results

Assured Guaranty Ltd. Declares Quarterly Dividend of $0.38 per Common Share

Molecular Partners publishes Phase 1 MP0317 data in Nature Cancer demonstrating tumor-localized CD40 activation and tumor microenvironment remodeling

OTC Markets Group Welcomes Silver Viper Minerals Corp. to OTCQX

Sachem Capital Sets Date for First Quarter 2026 Earnings Release and Conference Call

Terex Reports First Quarter 2026 Results

PPHC Expands MultiState Associates Stakeholder Engagement Capabilities